Birchview Capital as of Sept. 30, 2018
Portfolio Holdings for Birchview Capital
Birchview Capital holds 54 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 38.7 | $60M | 670k | 89.49 | |
| Accelr8 Technology | 32.4 | $50M | 2.2M | 22.95 | |
| Neurocrine Biosciences (NBIX) | 3.8 | $5.9M | 48k | 122.96 | |
| Quidel Corporation | 1.4 | $2.2M | 34k | 65.17 | |
| Vanda Pharmaceuticals (VNDA) | 1.3 | $2.0M | 88k | 22.95 | |
| Array BioPharma | 1.3 | $1.9M | 128k | 15.20 | |
| Encana Corp | 1.1 | $1.7M | 128k | 13.11 | |
| Contrafect | 1.1 | $1.6M | 797k | 2.07 | |
| Oxford Immunotec Global | 1.1 | $1.6M | 100k | 16.23 | |
| Vermillion | 1.0 | $1.6M | 2.2M | 0.71 | |
| Soleno Therapeutics | 0.9 | $1.4M | 657k | 2.16 | |
| Atara Biotherapeutics | 0.9 | $1.4M | 34k | 41.35 | |
| EQT Corporation (EQT) | 0.9 | $1.4M | 31k | 44.22 | |
| Clementia | 0.9 | $1.4M | 122k | 11.15 | |
| Sientra | 0.8 | $1.3M | 53k | 23.88 | |
| Albireo Pharma | 0.8 | $1.3M | 38k | 32.95 | |
| Arena Pharmaceuticals | 0.7 | $1.0M | 22k | 46.00 | |
| Masimo Corporation (MASI) | 0.6 | $996k | 8.0k | 124.50 | |
| Wright Medical | 0.6 | $871k | 30k | 29.03 | |
| Karyopharm Therapeutics | 0.6 | $852k | 50k | 17.04 | |
| G1 Therapeutics | 0.5 | $784k | 15k | 52.27 | |
| Biogen Idec (BIIB) | 0.5 | $707k | 2.0k | 353.50 | |
| Corcept Therapeutics Incorporated (CORT) | 0.5 | $701k | 50k | 14.02 | |
| Acceleron Pharma | 0.4 | $687k | 12k | 57.25 | |
| Dicerna Pharmaceuticals | 0.4 | $687k | 45k | 15.27 | |
| Amarin Corporation | 0.4 | $651k | 40k | 16.28 | |
| Dova Pharmaceuticals | 0.4 | $629k | 30k | 20.97 | |
| Voyager Therapeutics (VYGR) | 0.4 | $624k | 33k | 18.91 | |
| Nektar Therapeutics | 0.4 | $579k | 9.5k | 60.95 | |
| Intercept Pharmaceuticals In | 0.3 | $543k | 4.3k | 126.28 | |
| Inflarx Nv (IFRX) | 0.3 | $549k | 16k | 34.31 | |
| Pioneer Natural Resources | 0.3 | $523k | 3.0k | 174.33 | |
| Arvinas Ord (ARVN) | 0.3 | $506k | 30k | 16.87 | |
| Imprimis Pharmaceuticals | 0.3 | $500k | 180k | 2.78 | |
| Xencor (XNCR) | 0.3 | $479k | 12k | 38.94 | |
| Myriad Genetics (MYGN) | 0.3 | $460k | 10k | 46.00 | |
| Amicus Therapeutics (FOLD) | 0.3 | $459k | 38k | 12.08 | |
| Veracyte (VCYT) | 0.3 | $466k | 49k | 9.56 | |
| AVEO Pharmaceuticals | 0.3 | $397k | 120k | 3.31 | |
| Yield10 Bioscience | 0.2 | $390k | 271k | 1.44 | |
| Odonate Therapeutics Ord | 0.2 | $388k | 20k | 19.40 | |
| Axogen (AXGN) | 0.2 | $369k | 10k | 36.90 | |
| Opko Health (OPK) | 0.2 | $360k | 104k | 3.46 | |
| Tesaro | 0.2 | $320k | 8.2k | 39.02 | |
| Solid Biosciences | 0.2 | $283k | 6.0k | 47.17 | |
| Endocyte | 0.2 | $249k | 14k | 17.79 | |
| Oncomed Pharmaceuticals | 0.2 | $252k | 119k | 2.12 | |
| Sito Mobile (STTO) | 0.2 | $249k | 140k | 1.78 | |
| Genocea Biosciences | 0.1 | $147k | 189k | 0.78 | |
| Aevi Genomic | 0.1 | $157k | 128k | 1.23 | |
| Cytokinetics (CYTK) | 0.1 | $99k | 10k | 9.90 | |
| Biolase Technology | 0.1 | $83k | 40k | 2.07 | |
| Tg Therapeutics (TGTX) | 0.1 | $84k | 15k | 5.60 | |
| Workhorse Group Inc ordinary shares | 0.0 | $27k | 25k | 1.08 |
